Federal contract award
75D30122C14188
PROSPECTIVE COHORT TO EVALUATE THE IMMUNOGENICITY AND EFFECTIVENESS OF COVID-19 VACCINES AMONG FRONTLINE WORKERS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | CDC OFFICE OF ACQUISITION SERVICES |
| NAICS | 611310 — Colleges, Universities, and Professional Schools |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST NO FEE |
| Obligations | $21.7M |
| Current contract value | $21.7M |
| Potential contract value / ceiling | $21.7M |
| Start date | Jun 14, 2022 |
| Current end date | Dec 14, 2023 |
| Potential end date | Dec 14, 2023 |
| Latest award activity | Jun 4, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 6 of 6 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 4, 2026 | P00005 | $-728.9K | PROSPECTIVE COHORT TO EVALUATE THE IMMUNOGENICITY AND EFFECTIVENESS OF COVID-19 VACCINES AMONG FRONTLINE WORKERS |
| Sep 22, 2023 | P00004 | $0 | PROSPECTIVE COHORT TO EVALUATE THE IMMUNOGENICITY AND EFFECTIVENESS OF COVID-19 VACCINES AMONG FRONTLINE WORKERS |
| Apr 11, 2023 | P00003 | $0 | PROSPECTIVE COHORT TO EVALUATE THE IMMUNOGENICITY AND EFFECTIVENESS OF COVID-19 VACCINES AMONG FRONTLINE WORKERS |
| Jan 26, 2023 | P00002 | $0 | PROSPECTIVE COHORT TO EVALUATE THE IMMUNOGENICITY AND EFFECTIVENESS OF COVID-19 VACCINES AMONG FRONTLINE WORKERS |
| Oct 25, 2022 | P00001 | $0 | PROSPECTIVE COHORT TO EVALUATE THE IMMUNOGENICITY AND EFFECTIVENESS OF COVID-19 VACCINES AMONG FRONTLINE WORKERS |
| Jun 14, 2022 | 0 | $22.4M | PROSPECTIVE COHORT TO EVALUATE THE IMMUNOGENICITY AND EFFECTIVENESS OF COVID-19 VACCINES AMONG FRONTLINE WORKERS |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.